Compare CION & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CION | BVS |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 344.9M | 617.1M |
| IPO Year | 2011 | 2016 |
| Metric | CION | BVS |
|---|---|---|
| Price | $7.61 | $10.49 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $7.00 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 604.3K | 440.5K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 15.79% | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.33 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | N/A | $7.52 |
| Revenue Next Year | N/A | $7.06 |
| P/E Ratio | ★ $17.55 | $32.03 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.50 | $5.81 |
| 52 Week High | $10.93 | $10.58 |
| Indicator | CION | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 59.84 | 75.21 |
| Support Level | $6.55 | $8.43 |
| Resistance Level | $10.21 | N/A |
| Average True Range (ATR) | 0.25 | 0.37 |
| MACD | 0.13 | 0.11 |
| Stochastic Oscillator | 98.04 | 99.74 |
CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Companies portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans, and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation for investors.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.